The time is ripe for oocyte in vitro maturation

• DOI: 10.1007/s10815-021-02209-x
• Publication Date: 2021-05-08T06:05:44Z
• Authors: Carlos E. Plancha; Patrícia Rodrigues; Mónica Marques; Joana M. Almeida; Paulo Navarro-Costa
• Keywords: In vitro maturation; Oocyte donation

When it comes to welcome transitions 2021 seems to have started on a promising note. From the ushering in of COVID-19 vaccination programs to a renewed appreciation of evidence-based policy in many countries progress manifested itself in swift and emphatic manners. The same can be said of the field of assisted reproduction techniques (ART) home to a recent practice committee document on oocyte in vitro maturation (IVM) [1]. In this landmark document the practice committees of the American Society for Reproductive Medicine (ASRM) the Society of Reproductive Biologists and Technologists and the Society for Assisted Reproductive Technology (SART) present a considerable (and compelling) body of published evidence supporting the conclusion that IVM should no longer be considered an experimental technique.<br/>© The Author(s) 2021.<br/>Study partially supported by a Fundação para a Ciência e a Tecnologia grant (PTDC/MEC-AND/30221/2017).<br/>